Brief: Yidu Tech Says Successful Bidding Of Phase I Clinical Trial From China Resources
Oct 26 (Reuters) - Yidu Tech Inc 2158.HK :
* SUCCESSFUL BIDDING OF PHASE I CLINICAL TRIAL FROM CHINA
RESOURCES
* BID FOR RMB13.7 MILLION
* BID FOR PHASE I CLINICAL TRIAL OF SAFETY, TOLERABILITY OF
A
SINGLE DOSE OF CRB4101 IN HEALTHY ADULT SUBJECTS
Further company coverage: 2158.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Yidu Tech
See all newsBrief: Yidu Tech Says Cloud Affiliate Wins Bid For Construction Project At Xiangya Hospital
Brief: Yidu Tech Enters MoU For Proposed Acquisition Of Co Engaged In Online Doctors’ Platform
Brief: Yidu Tech Says Cloud Wins Chongqing Fuling Hospital Data Center Project
Brief: Yidu Tech Says Affiliate Wins Smart Clinical Upgrade Project Worth RMB9.08 MLN
Brief: Yidu Tech's Unit Wins Singapore Health Services Dr Buddy Project Worth S$2.3 Mln